Celldex Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Celldex Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 192% to $6,883,000. Profit margin reached -2055%. Total operating expenses were $161,425,000.
Profit Margin
| 2014 | 3.58M | -118.08M | -3292.81% |
|---|---|---|---|
| 2015 | 5.48M | -127.19M | -2321.11% |
| 2016 | 6.78M | -128.53M | -1894.05% |
| 2017 | 12.74M | -93.03M | -730.06% |
| 2018 | 9.53M | -151.18M | -1585.07% |
| 2019 | 3.57M | -50.37M | -1409.8% |
| 2020 | 7.41M | -59.78M | -805.88% |
| 2021 | 4.65M | -70.51M | -1516.04% |
| 2022 | 2.35M | -122.78M | -5209.29% |
| 2023 | 6.88M | -141.42M | -2054.76% |
CLDX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 6.88M | 2.35M | 4.65M | 7.41M | 3.57M | 9.53M | 12.74M | 6.78M | 5.48M | 3.58M |
Cost of revenue | 3.00M | 1.4M | 3.06M | 42.53M | 42.67M | 0 | 96.17M | 0 | 4.01M | 101.88M |
Gross profit | 3.87M | 957K | 1.58M | -35.11M | -39.09M | 9.53M | -83.42M | 6.78M | 1.46M | -98.29M |
Operating exp. | ||||||||||
Research and development | 118.01M | 82.25M | 53.31M | 42.53M | 42.67M | 66.44M | 96.17M | 102.72M | 100.17M | 104.38M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 161.42M | 109.45M | 73.79M | 56.99M | 58.09M | 85.94M | 122.07M | 139.70M | 135.02M | 126.01M |
Operating income | -154.54M | -115.23M | -71.24M | -63.35M | -55.03M | -156.43M | -121.52M | -132.91M | -129.54M | -122.43M |
Other income (expenses), net | 13.11M | 2.90M | 505K | 2.40M | 4.15M | -75.54M | 4.21M | 4.38M | 2.34M | 4.35M |
Income before tax | -141.42M | -112.32M | -70.73M | -60.94M | -50.87M | -151.94M | -117.31M | -128.53M | -127.19M | -118.08M |
Income tax expense | 0 | 10.45M | -227K | -1.16M | -506K | -765K | -24.28M | -8.77M | -2.34M | -4.35M |
Net income | -141.42M | -122.78M | -70.51M | -59.78M | -50.37M | -151.18M | -93.03M | -128.53M | -127.19M | -118.08M |
Earnings per share | ||||||||||
Basic EPS | -2.92 | -2.62 | -1.64 | -2.02 | -3.47 | -14.48 | -10.86 | -18.99 | -19.66 | -19.81 |
Diluted EPS | -2.92 | -2.62 | -1.64 | -2.02 | -3.47 | -14.48 | -10.86 | -18.99 | -19.66 | -19.81 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |